Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen - UV-A for the treatment of chronic plaque psoriasis

Archives of Dermatology

Volumn 139, Issue 3, 2003, Pages 325-328

  Markham, Trevor ^a   Rogers, S ^a   Collins, P ^a  

^a City of Dublin Skin/Cancer Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DELTAPSORALEN; METHOXSALEN;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL; RASH; ULTRAVIOLET B RADIATION;

ADMINISTRATION, ORAL; ADULT; CHRONIC DISEASE; FEMALE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PSORIASIS; RADIOMETRY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; WHOLE-BODY IRRADIATION;

EID: 0037342633     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.3.325     Document Type: Article

References (28)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974;291:1207-1211.
2. Wolff K, Fitzpatrick TB, Parrish JA, et al. Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol. 1976;112:943-950.
3. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol. 1977;68:328-335.
4. Henseler T, Hönigsmann, Wolff K, Christophers E. Oral 8 methoxypsoralen photochemotherapy of psoriasis. Lancet. 1981;1:853-857.
5. Rogers S, Marks J, Shuster S, Briffa DV, Warin A, Greaves M. Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet 1979;1:455-458.
6. Linelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiological study. Lancet. 1991;338:91-93.
7. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysis. Arch Dermatol. 1998;134:1582-1585.
8. Stern R, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer. 1994;73:2759-2764.
9. Stern R. The risk of melanoma in association with long term exposure to PUVA. J Am Acad Dermatol. 2001;44:755-761.
10. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359-362.
11. Fisher T. UV-light treatment of psoriasis. Derm Venereol. 1976;56:473-479.
12. Van Weelden H, De la Faille HB, Young E, Van Der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-19.
13. British Photodermatology Group. An appraisal of narrowband (TL01) UVB phototherapy: British Photodermatology Group Workshop Report (April 1996). Br J Dermatol. 1997;137:327-330.
14. Green C, Ferguson J, Lakshmipathi, Johnson BE. 311nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol. 1988;119:691-696.
15. Storbeck K, Hölze E, Schürer N, Lehmann P, Plewig G. Narrow-band UVB (311nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol. 1993;28:227-231.
16. Coven TR, Burack LH, Gilleaudeau P, Keogh M, Dzawa M, Krueger JG. Narrowband UVB produces superior clinical and histological resolution of moderate to severe psoriasis I patients compared with broadband UVB. Arch Dermatol. 1997;133:1514-1522.
17. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol. 1992;127:509-512.
18. Larkö O. Treatment of psoriasis with a new lamp. Acta Derm Venereol (Stockh). 1989;69:357-359.
19. Markham T, Collins P. An audit of adverse effects of oral 8-methoxypsoralen ultraviolet (UV)A and narrowband UVB phototherapy in the management of chronic plaque psoriasis [abstract]. Br J Dermatol. 2001;145(suppl 59):44.
20. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet. 1995;345:1431-1432.
21. De Gruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR, eds. The Fundamental Bases of Phototherapy. Milan, Italy; DEMF Spa; 1996:153-170.
22. Van Weelden H, De la Faille HB, Young E, Van Der Leun JC. Comparison of narrowband UVB phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol. 1990;70:212-215.
23. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque psoriasis. Arch Dermatol. 1999;135:519-524.
24. Gordon PM, Diffey L, Matthews JNS, Farr PM. A randomised comparison of narrowband TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol. 1999;41:728-732.
25. Dawe RS, Cameron H, Yule S, et al. A comparison of TL01 UVB phototherapy and bath-PUVA for chronic plaque psoriasis [abstract]. Br J Dermatol. 2000;143(suppl 57):15.
26. De Berker DAR, Sakuntabhai A, Diffey BL, Farr PM. Comparison of psoralen-UVB and psoralen UVA photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol. 1997;36:577-581.
27. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol. 1999;139:933-939.
28. Gibson G, Codd MB, Murphy GM. Skin type distribution and skin disease in Ireland. Ir J Med Sci. 1997;166:72-74.